Logo image of TLC

Taiwan Liposome Company Ltd ADR (TLC) Stock Price, Quote, News and Overview

NASDAQ:TLC - Nasdaq -

7  0 (0%)

TLC Quote, Performance and Key Statistics

Taiwan Liposome Company Ltd ADR

NASDAQ:TLC (9/28/2021, 8:00:01 PM)

7

0 (0%)

Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
Statistics
52 Week High7.7
52 Week Low4.07
Market Cap294.54M
Shares42.08M
Float42.08M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)01-11 2022-01-11
IPON/A N/A


TLC short term performance overview.The bars show the price performance of TLC in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 10 15 20

TLC long term performance overview.The bars show the price performance of TLC in the last 1, 2 and 3 years. 1 year 2 years 3 years 10 20 30 40 50

The current stock price of TLC is 7 null. In the past month the price decreased by -2.78%. In the past year, price increased by 59.45%.

Taiwan Liposome Company Ltd ADR / TLC Daily stock chart

About TLC

Company Profile

Taiwan Liposome Company Ltd. is a specialty pharmaceutical company. It focuses on development and commercialization of novel nanomedicines designed to target unmet medical need in pain management, ophthalmology and oncology. The company's product pipeline consists of TLC599, TLC590, TLC399 and TLC178 which are in clinical stage. Taiwan Liposome Company Ltd. is headquartered in Taipei City, Taiwan.

Company Info

Taiwan Liposome Company Ltd ADR

11TH FLOOR-1 YUANQU STREET NANGANG DISTRICT

TAIPEI CITY F5 11503

CEO: Keelung Hong

Phone: 886-2-2655-7377

Taiwan Liposome Company Ltd ADR / TLC FAQ

What is the stock price of Taiwan Liposome Company Ltd ADR today?

The current stock price of TLC is 7 null.


What is the ticker symbol for Taiwan Liposome Company Ltd ADR stock?

The exchange symbol of Taiwan Liposome Company Ltd ADR is TLC and it is listed on the Nasdaq exchange.


On which exchange is TLC stock listed?

TLC stock is listed on the Nasdaq exchange.


What is Taiwan Liposome Company Ltd ADR worth?

Taiwan Liposome Company Ltd ADR (TLC) has a market capitalization of 294.54M null. This makes TLC a Micro Cap stock.


What are the support and resistance levels for Taiwan Liposome Company Ltd ADR (TLC) stock?

Taiwan Liposome Company Ltd ADR (TLC) has a support level at 6.99 and a resistance level at 7.05. Check the full technical report for a detailed analysis of TLC support and resistance levels.


Is Taiwan Liposome Company Ltd ADR (TLC) expected to grow?

The Revenue of Taiwan Liposome Company Ltd ADR (TLC) is expected to decline by -35.08% in the next year. Check the estimates tab for more information on the TLC EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy Taiwan Liposome Company Ltd ADR (TLC) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does Taiwan Liposome Company Ltd ADR (TLC) stock pay dividends?

TLC does not pay a dividend.


When does Taiwan Liposome Company Ltd ADR (TLC) report earnings?

Taiwan Liposome Company Ltd ADR (TLC) will report earnings on 2022-01-11.


What is the Price/Earnings (PE) ratio of Taiwan Liposome Company Ltd ADR (TLC)?

Taiwan Liposome Company Ltd ADR (TLC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.69).


TLC Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to TLC. When comparing the yearly performance of all stocks, TLC is one of the better performing stocks in the market, outperforming 84.9% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

TLC Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to TLC. Both the profitability and financial health of TLC have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

TLC Financial Highlights

Over the last trailing twelve months TLC reported a non-GAAP Earnings per Share(EPS) of -0.69. The EPS increased by 21.61% compared to the year before.


Industry RankSector Rank
PM (TTM) -291.85%
ROA -60.71%
ROE N/A
Debt/Equity 0.67
Chartmill High Growth Momentum
EPS Q2Q%90.91%
Sales Q2Q%1353.56%
EPS 1Y (TTM)21.61%
Revenue 1Y (TTM)397.16%

TLC Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 80% to TLC. The Buy consensus is the average rating of analysts ratings from 2 analysts.

For the next year, analysts expect an EPS growth of 4.76% and a revenue growth -35.08% for TLC


Ownership
Inst Owners0.22%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
Analysts
Analysts80
Price TargetN/A
EPS Next Y4.76%
Revenue Next Year-35.08%